- Home
- ERNA vs TPST Comparison
ERNA vs TPST Comparison
Compare ERNA & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERNA | TPST |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 11.3M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ERNA | TPST |
|---|---|---|
| Price | $0.29 | $2.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 1.5M | 55.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.10 | ★ 21.47 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $582,000.00 | $295,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 755.88 | N/A |
| 52 Week Low | $0.15 | $0.60 |
| 52 Week High | $3.00 | $12.22 |
Technical Indicators
Market Signals| Indicator | ERNA | TPST |
|---|---|---|
| Relative Strength Index (RSI) | 25.32 | 37.06 |
| Support Level | $0.27 | $2.16 |
| Resistance Level | $0.40 | $3.18 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 18.62 | 35.44 |
Price Performance
Historical ComparisonAbout ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.